RxDoctor Payments Data

Faisal Bakaeen, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Houston, TXNPI 1811908700

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $6,427 of the $9,073 with a category attached, or 70.8%. Edwards Lifesciences accounts for 75.6% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $7,220 and has fallen 87.8% since, to $883 in 2025.

$9,073in general payments, 2019–2025

Across 28 payments — averaging $324.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$7K
  • JACE Medical LLC$537
  • Medistim USA, Inc.$412
  • Corcym Inc$377
  • Bolton Medical Inc$252
  • Dilon Technologies, Inc.$183
  • plus $452 from 6 others
$35,766in research payments, 2019–2025

Across 6 payments — averaging $5960.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Vascular Graft Solutions Inc$36K

What the payments were for

  • Consulting fees$5376%
  • Travel & lodging$6,42771%
  • Food & beverage$2,10923%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Edwards Lifesciences4$6,861
JACE Medical LLC2$537
Medistim USA, Inc.2$412
Corcym Inc4$377
Bolton Medical Inc2$252
Dilon Technologies, Inc.3$183
Medtronic(2 entities)3$171
Atricure, Inc.3$106
Baxter Healthcare2$63
Supreme Orthopedic Systems, LLC1$42
Covidien LP1$36
Nexus Medical Technologies LLC1$33

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,073 in reported general payments places this provider in the 55th percentile of 424 thoracic surgery (cardiothoracic vascular surgery) providers in Texas.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Texas →

Medicare billing

Part B allowed, 2024
$253,663
Medicare patients
127
Services billed
344

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Houston

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →